http://www.pharmtech.com/pharmtech/Ingredients/Article/list/40942 Trends, market analysis, and market growth reports on pharmaceutical ingredient suppliers and manufacturers. Sourcing and supply of active pharmaceutical ingredients (APIs), intermediates, excipients. 2013-05-20T19:49:07Z http://www.pharmtech.com/pharmtech/Ingredients/Using-Thermal-Ink-Jet-Printing-Technology-to-Produ/ArticleStandard/Article/detail/813397?contextCategoryId=40942&ref=25 Cocrystals are used to improve the performance of APIs that have non-ideal physiochemical properties by cocrystallizing the API with a second compound that modulates the API to provide a way to improve a drug's bioavailability, stability, and processability. 2013-05-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813397null XML http://www.pharmtech.com/pharmtech/Ingredients+Insider/Intellectual-Property-Battles-in-Solid-State-Chemi/ArticleStandard/Article/detail/813405?contextCategoryId=40942&ref=25 The rejection by India's Supreme Court on Novartis' Glivec/Gleevec (imatinib mesylate) and other recent case law raise important issues on patent strategies for solid forms. 2013-05-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813405/pt0513_api_thumb_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813405null XML http://www.pharmtech.com/pharmtech/Ingredients/Academic-and-Public-Partnerships-in-Solid-State-Ch/ArticleStandard/Article/detail/813400?contextCategoryId=40942&ref=25 Solid-state chemistry is an important part of drug development, and public research is advancing the field. 2013-05-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/202013/813400null XML http://www.pharmtech.com/pharmtech/Feature+Articles/Navigating-the-Global-Manufacturing-Supply-Chain/ArticleStandard/Article/detail/809034?contextCategoryId=40942&ref=25 As the strategic value of emerging markets increase, pharmaceutical companies increase their R&D and manufacturing investments. 2013-03-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/142013/809034/146672066-globes-inside-a-capsule-gettyimages_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/142013/809034null XML http://www.pharmtech.com/pharmtech/Ingredients/Adhering-to-ICH-Q7-for-GMPs/ArticleStandard/Article/detail/809039?contextCategoryId=40942&ref=25 FDA's requirements for API manufacturers in regards to ICH Q7. 2013-03-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/142013/809039null XML http://www.pharmtech.com/pharmtech/Formulation/Measuring-API-Particle-Size-Distribution/ArticleStandard/Article/detail/809028?contextCategoryId=40942&ref=25 Visual mapping can provide a particle-size distribution estimate. 2013-03-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/142013/809028null XML http://www.pharmtech.com/pharmtech/Feature+Articles/Quality-by-Design-in-Excipients/ArticleStandard/Article/detail/809045?contextCategoryId=40942&ref=25 Factors for assessing excipient variability, the associated challenges developers need to address to design and manufacture solid oral drug products, and solutions for such challenges are examined. 2013-03-01T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/142013/809045/85784530_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/142013/809045null XML http://www.pharmtech.com/pharmtech/Feature+Articles/Standardizing-Excipient-Information-to-Achieve-Sup/ArticleStandard/Article/detail/809043?contextCategoryId=40942&ref=25 The use of various documents and guides by the International Pharmaceutical Excipients Council can facilitate the flow of information among excipient manufacturers, distributors, and users. 2013-03-01T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/142013/809043/97247181_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/142013/809043null XML http://www.pharmtech.com/pharmtech/Feature+Articles/Advancing-Polymers-for-Solubility-Enhancement/ArticleStandard/Article/detail/809041?contextCategoryId=40942&ref=25 Pharmaceutical Technology brought together a panel of industry experts for a special forum to discuss solubilizing polymers and the related formulation strategies for poorly soluble drugs. 2013-03-01T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/142013/809041/78374356_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/142013/809041null XML http://www.pharmtech.com/pharmtech/Ingredients/Gaining-Stereoselectivity-in-Asymmetric-Synthesis/ArticleStandard/Article/detail/804861?contextCategoryId=40942&ref=25 Researchers use inorganic catalysts as an alternative to biocatalysts in the selective conversion of sugars to produce chiral building blocks. 2013-02-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/062013/804861/molecule_white_blue_thumbnail.gif http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/062013/804861null XML http://www.pharmtech.com/pharmtech/Ingredients/The-Class-of-2012-for-New-Molecular-Entities-and-B/ArticleStandard/Article/detail/799117?contextCategoryId=40942&ref=25 As 2012 comes to a close, Pfizer leads among Big Pharma companies for FDA approvals of new molecular entities and biologics. 2012-12-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492012/799117/Molecule_blue_thumbnail.gif http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492012/799117null XML http://www.pharmtech.com/pharmtech/Ingredients/Partnering-in-Antibody-Drug-Conjugates/ArticleStandard/Article/detail/795601?contextCategoryId=40942&ref=25 The promise of antibody drug conjugates is creating a network of partners among large pharma companies and specialized players. 2012-11-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/452012/795601/DNA_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/452012/795601null XML http://www.pharmtech.com/pharmtech/Ingredients/Analytical-Applications/ArticleStandard/Article/detail/795587?contextCategoryId=40942&ref=25 Developing analytical methods and performing related testing is crucial for ensuring the quality of a pharmaceutical product. 2012-11-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/452012/795587/LabWork_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/452012/795587null XML http://www.pharmtech.com/pharmtech/Ingredients/Obtaining-Stable-Homogenous-Mixtures-with-Microniz/ArticleStandard/Article/detail/791902?contextCategoryId=40942&ref=25 The authors examine the use of various grades of direct-compression mannitol in direct-compression tableting process to evaluate the content uniformity of micronized APIs and excipients in a solid-dosage formulation. 2012-10-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/412012/791902/138087090_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/412012/791902null XML http://www.pharmtech.com/pharmtech/Ingredients+Insider/Advancing-Protein-Crystallization-Microgravity-Eff/ArticleStandard/Article/detail/791892?contextCategoryId=40942&ref=25 Recent research on elucidating the structure and sequence of proteins involves examining the effect of microgravity on protein crystallization and a computational model for protein elucidation. 2012-10-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/412012/791892null XML http://www.pharmtech.com/pharmtech/Ingredients+Insider/Seeking-Solutions-in-Solid-State-Chemistry/ArticleStandard/Article/detail/791914?contextCategoryId=40942&ref=25 Particle-engineering technologies, such as crystal design for crystallization and producting cocrystals, particle-size reduction, and amorphous solid dispersions, help to optimize delivery of a drug. 2012-10-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/412012/791914/138142861-vitamin-c_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/412012/791914null XML http://www.pharmtech.com/pharmtech/Ingredients/Shifts-in-Pharma-Capital-Agendas/ArticleStandard/Article/detail/791915?contextCategoryId=40942&ref=25 The long-awaited patent cliff that has loomed in the pharmaceutical industry for years has arrived in earnest in 2012, with more than $40 billion in 2011 brand sales facing loss of exclusivity. 2012-10-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/412012/791915/Dollars_thumbnail.gif http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/412012/791915null XML http://www.pharmtech.com/pharmtech/Whitepapers/Drug-Layering-onto-Fine-Particles/ArticleStandard/Article/detail/753895?contextCategoryId=40942&ref=25 We evaluate special low viscosity hydroxypropyl cellulose (HPC-SSL) as a novel binder for drug-layering onto fine particles by spouted-bed spraying process 2012-09-25T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/522011/753895null REMOTE http://www.pharmtech.com/pharmtech/News/Bristol-Myers-Squibb-Issues-Voluntary-Recall-of-Ca/ArticleStandard/Article/detail/787292?contextCategoryId=40942&ref=25 Bristol-Myers Squibb has initiated a voluntary recall of 10 lots of BiCNU (carmustine for injection) previously manufactured by Ben Venue Laboratories, a former, third-party contract manufacturer for the company, to the user level. 2012-09-04T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362012/787292null HTML http://www.pharmtech.com/pharmtech/Ingredients/Peer-Reviewed-Numerical-Simulation-of-Tablet-Coati/ArticleStandard/Article/detail/787766?contextCategoryId=40942&ref=25 The authors investigate the tablet-coating process using a combination of different simulation techniques. 2012-09-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362012/787766/PT0912_53_Peer1588-Fig2_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362012/787766null XML http://www.pharmtech.com/pharmtech/Ingredients+Insider/Meeting-Challenges-in-Asymmetric-Synthesis/ArticleStandard/Article/detail/787760?contextCategoryId=40942&ref=25 Industry and academia advance novel approaches for achieving enanioselectivity. 2012-09-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362012/787760null XML http://www.pharmtech.com/pharmtech/Ingredients/246-Tribromoanisole-and-246-Trichloroanisole/ArticleStandard/Article/detail/787765?contextCategoryId=40942&ref=25 A review of taints and odors in the pharmaceutical and consumer healthcare industries. 2012-09-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362012/787765/PT0912_56_136494323-overhead-shot-of-medical-pills-gettyimages_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362012/787765null XML http://www.pharmtech.com/pharmtech/Ingredients/Plant-Focus-High-Potency-Manufacturing-and-Sustain/ArticleStandard/Article/detail/788777?contextCategoryId=40942&ref=25 Pfizer has two manufacturing facilities in Germany for high-potency manufacturing, respectively in Freiburg and Illertissen. Pharmaceutical Technology's Executive Editor Patricia Van Arnum visited the facilities and spoke to the company about the design and operation of these facilities. 2012-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/372012/788777null XML http://www.pharmtech.com/pharmtech/Ingredients/Fast-Locator-2012-2013-API-and-Advanced-Intermedia/ArticleStandard/Article/detail/787670?contextCategoryId=40942&ref=25 Companies' outsourcing profiles from PharmTech's 2012 Outsourcing Resources Fast Locator Index. 2012-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362012/787670null HTML http://www.pharmtech.com/pharmtech/Ingredients/Weighing-Access-and-Affordability/ArticleStandard/Article/detail/787881?contextCategoryId=40942&ref=25 Policymakers must balance fundamental issues involving access to medicines and pricing. 2012-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362012/787881null XML http://www.pharmtech.com/pharmtech/Ingredients/Moving-to-Risk-Based-Inspections/ArticleStandard/Article/detail/787882?contextCategoryId=40942&ref=25 The author discusses the key provisions of GDUFA as they relate to the pharmaceutical supply chain, including parity of inspections between domestic and foreign sites for both finished dosage forms and APIs of generic drugs. 2012-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362012/787882null XML http://www.pharmtech.com/pharmtech/Ingredients/Achieving-Process-Understanding-and-Control-in-Fil/ArticleStandard/Article/detail/787883?contextCategoryId=40942&ref=25 The authors describe a QbD study that was performed to optimize a coating system. 2012-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362012/787883null XML http://www.pharmtech.com/pharmtech/Ingredients/Strategies-for-High-Containment/ArticleStandard/Article/detail/787878?contextCategoryId=40942&ref=25 An industry roundtable representing Metrics, Cambrex, Carbogen Amcis, Euticals, Ferro Pfanstiehl, and SAFC. 2012-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362012/787878/PTsupp0912_S6_SAFC-LMA_GloveBox316_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362012/787878null XML http://www.pharmtech.com/pharmtech/Ingredients/Making-API-Synthesis-Greener/ArticleStandard/Article/detail/787879?contextCategoryId=40942&ref=25 The authors explain chemical transformations that are achievable through certain biocatalytic routes. 2012-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362012/787879/PTsupp0912_S12_147219903-varenicline-drug-molecule-gettyimages_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362012/787879null XML http://www.pharmtech.com/pharmtech/Analytics/Fast-Locator-2012-2013-Index/ArticleStandard/Article/detail/783000?contextCategoryId=40942&ref=25 View companies' outsourcing profiles from PharmTech's 2012 Outsourcing Resources Fast Locator Index in the following categories. 2012-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/302012/783000null HTML http://www.pharmtech.com/pharmtech/Ingredients/Pharmaceutical-Based-Cargo-Security-and-Theft-Prev/ArticleStandard/Article/detail/783930?contextCategoryId=40942&ref=25 The author discusses strategies for preventing cargo theft. 2012-08-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/312012/783930/PT0812_NonPeer-CargoTheft__Web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/312012/783930null XML http://www.pharmtech.com/pharmtech/Ingredients+Insider/Scaling-up-API-Syntheses/ArticleStandard/Article/detail/783938?contextCategoryId=40942&ref=25 Approaches to scaling up API syntheses center on ways to optimize process conditions and operability. 2012-08-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/312012/783938/PT0812_Ingredients__Web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/312012/783938null XML http://www.pharmtech.com/pharmtech/Outsourcing+Outlook/Gauging-Biopharm-Outsourcing/ArticleStandard/Article/detail/783928?contextCategoryId=40942&ref=25 Budgets for biopharmaceutical activities are gaining in select functional areas except outsourcing. 2012-08-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/312012/783928null XML http://www.pharmtech.com/pharmtech/Ingredients/Bioavailability-Enhancement-When-to-Use-Hot-Melt-E/ArticleStandard/Article/detail/783937?contextCategoryId=40942&ref=25 Enhancing bioavailability can be achieved through hot-melt extrusion or spray drying. Patricia Van Arnum interviews Bend Research to find out more about when to use each technique. 2012-08-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/312012/783937/solubility_thumbnail.gif http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/312012/783937null XML http://www.pharmtech.com/pharmtech/Ingredients/A-Manufacturing-Capacity-Sharing-Model-Merck-amp-C/ArticleStandard/Article/detail/783918?contextCategoryId=40942&ref=25 The manufacturing capacity-sharing model in biologics and Merck & Co. and MedImmune ushers in a new paradigm of "co-opetition". 2012-08-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/312012/783918/PT0812_Supp_MedImmuneR1_Web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/312012/783918null XML http://www.pharmtech.com/pharmtech/Ingredients/Market-Strengths-and-Weaknesses-in-Biosimilars/ArticleStandard/Article/detail/783920?contextCategoryId=40942&ref=25 An examination of the current and projected market for biosimilars, development costs for biosimilars compared with small-molecule generic drug, and partnerships in biosimilars. 2012-08-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/312012/783920/PT0812_Supp_Biosimilars__Web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/312012/783920null XML http://www.pharmtech.com/pharmtech/Ingredients/35th-Anniversary-Special-Whats-Ahead-in-Chemical-A/ArticleStandard/Article/detail/781190?contextCategoryId=40942&ref=25 Flow chemistry and microreactors offer alternatives to traditional batch manufacturing. 2012-07-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/282012/781190null XML http://www.pharmtech.com/pharmtech/Ingredients/A-New-RampD-Paradigm/ArticleStandard/Article/detail/781198?contextCategoryId=40942&ref=25 Holistic open learning networks offer a new drug R&D model for improving research outcomes. 2012-07-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/282012/781198null XML http://www.pharmtech.com/pharmtech/Ingredients+Insider/High-Potency-Manufacturing-Remains-Strong/ArticleStandard/Article/detail/781188?contextCategoryId=40942&ref=25 Companies roll out expansions in manufacturing high-potency APIs and finished products. 2012-07-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/282012/781188/PT0712_122375658_4c_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/282012/781188null XML http://www.pharmtech.com/pharmtech/Outsourcing+Outlook/Reflecting-on-35-Years-of-Procurement-Transformati/ArticleStandard/Article/detail/781191?contextCategoryId=40942&ref=25 The past three decades have driven a purchasing evolution to a procurement revolution. 2012-07-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/282012/781191null XML http://www.pharmtech.com/pharmtech/Ingredients/35th-Anniversary-Special-Decades-of-Change-for-the/ArticleStandard/Article/detail/781207?contextCategoryId=40942&ref=25 Tracking changes from spinoffs of chemical companies to life-sciences powerhouses. 2012-07-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/282012/781207/PT0712_Table-III_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/282012/781207null XML http://www.pharmtech.com/pharmtech/Ingredients/35th-Anniversary-Special-New-Models-in-Contract-Se/ArticleStandard/Article/detail/781187?contextCategoryId=40942&ref=25 Sponsor companies' increasing focus on strategic outsourcing has changed the rules of the game. 2012-07-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/282012/781187null XML http://www.pharmtech.com/pharmtech/Ingredients/A-Look-into-the-Future-of-Pharmaceutical-Outsourci/ArticleStandard/Article/detail/781200?contextCategoryId=40942&ref=25 Jim Miller, president of PharmSource, examines the future direction of CROs/CMOs and the factors influencing the pharmaceutical contract services sectors. 2012-07-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/282012/781200null XML http://www.pharmtech.com/pharmtech/Ingredients/Innovation-Boom-Towns/ArticleStandard/Article/detail/775996?contextCategoryId=40942&ref=25 Partnerships between industry and academic medical centers are expanding to meet R&D needs. 2012-06-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/222012/775996null XML http://www.pharmtech.com/pharmtech/Outsourcing+Outlook/Biomanufacturing-Innovation/ArticleStandard/Article/detail/775989?contextCategoryId=40942&ref=25 Industry wants more innovation, but can suppliers meet customer needs? 2012-06-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/222012/775989null XML http://www.pharmtech.com/pharmtech/Ingredients+Insider/Peptides-Gain-Traction-in-Drug-Development/ArticleStandard/Article/detail/775990?contextCategoryId=40942&ref=25 Peptides and related technologies to are starting to improve production. 2012-06-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/222012/775990/PT0612_42_sb10063846s-001_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/222012/775990null XML http://www.pharmtech.com/pharmtech/Ingredients/Tackling-Global-Health-Concerns/ArticleStandard/Article/detail/771900?contextCategoryId=40942&ref=25 Industry, the public sector, and individuals can play an important role in creating solutions. 2012-05-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182012/771900null XML http://www.pharmtech.com/pharmtech/Ingredients+Insider/Seeking-Chemocatalytic-and-Biocatalytic-Solutions/ArticleStandard/Article/detail/771902?contextCategoryId=40942&ref=25 Advances in palladium-catalyzed hydrogenation, visible-light photocatalysis, and chemocatalyisis for heterocycles are some recent developments. 2012-05-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182012/771902/PT0512_142022463_56_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/182012/771902null XML http://www.pharmtech.com/pharmtech/Ingredients/Inside-INFORMEX-Evaluating-the-Market-for-Contract/ArticleStandard/Article/detail/768881?contextCategoryId=40942&ref=25 Contract API manufacturers and fine-chemical producers roll out capacity and service expansions. 2012-04-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/152012/768881/PT0412_Inside_Web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/152012/768881null XML http://www.pharmtech.com/pharmtech/Ingredients/Expanding-Excipient-Portfolios/ArticleStandard/Article/detail/768865?contextCategoryId=40942&ref=25 Excipient manufacturers expand production capacity and partner to broaden their offerings. 2012-04-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/152012/768865/PT0412_Ingredients_Web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/152012/768865null XML http://www.pharmtech.com/pharmtech/Ingredients/A-Sustainable-Biotech-Path/ArticleStandard/Article/detail/768860?contextCategoryId=40942&ref=25 With financing constrained, biotechnology firms must find ways to sustain innovation. 2012-04-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/152012/768860null XML http://www.pharmtech.com/pharmtech/Ingredients/Evaluating-Impurities-in-Drugs-Part-III-of-III/ArticleStandard/Article/detail/768870?contextCategoryId=40942&ref=25 In Part III of a three-part article, the authors examine various degradation routes of APIs, impurities arising from interactions in formulations, metabolite impurities, various analytical methods to measure impuritie, and ways to control impurities. 2012-04-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/152012/768870/PT0412_Peer_Web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/152012/768870null XML http://www.pharmtech.com/pharmtech/Outsourcing+Outlook/CMOs-Face-a-Kodak-Moment/ArticleStandard/Article/detail/763971?contextCategoryId=40942&ref=25 The evolving bio/pharmaceutical business model poses risk for CMOs. 2012-03-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/102012/763971null XML http://www.pharmtech.com/pharmtech/Ingredients/Defining-Conflict-of-Interest/ArticleStandard/Article/detail/763940?contextCategoryId=40942&ref=25 The divide between innovation and conflict of interest in medical research is not so clear. 2012-03-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/102012/763940null XML http://www.pharmtech.com/pharmtech/Ingredients+Insider/Securing-the-Pharma-Supply-Chain/ArticleStandard/Article/detail/763941?contextCategoryId=40942&ref=25 Regulatory bodies, standard-setting organizations, and industry seek to tackle the problem of counterfeit drugs and securing the flow of pharma ingredients. 2012-03-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/102012/763941null XML http://www.pharmtech.com/pharmtech/Ingredients/Advances-in-Taste-masking/ArticleStandard/Article/detail/763954?contextCategoryId=40942&ref=25 Taste-masking is an important consideration to ensure patient compliance. 2012-03-01T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/102012/763954/PTsupp0312_S10_97247181_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/102012/763954null XML http://www.pharmtech.com/pharmtech/Ingredients/Standardized-Excipient-GMP/ArticleStandard/Article/detail/763953?contextCategoryId=40942&ref=25 This article provides guidance for industry on how to comply with the pending American National Standard on excipient GMP, with a focus on risk assessment. 2012-03-01T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/102012/763953/PTsupp0312_S42_82143603_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/102012/763953null XML http://www.pharmtech.com/pharmtech/Ingredients/Physical-Chemical-Identifiers-A-QampA-with-FDA-on-/ArticleStandard/Article/detail/763951?contextCategoryId=40942&ref=25 FDA answers key questions about the October 2011 guidance on using physical–chemical identifiers in solid oral dosage products to help prevent and avoid counterfeiting. 2012-03-01T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/102012/763951null XML http://www.pharmtech.com/pharmtech/Ingredients/The-American-National-Standard-for-Excipient-GMP/ArticleStandard/Article/detail/763949?contextCategoryId=40942&ref=25 The author reviews significant changes to GMP for excipients in the forthcoming American National Standard, including a risk-based approach to excipient manufacture, why new requirements were proposed, and their potential impact to excipient manufacturers. 2012-03-01T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/102012/763949null XML http://www.pharmtech.com/pharmtech/Ingredients/Formulation-Development-Forum-Boronate-Cross-linke/ArticleStandard/Article/detail/757443?contextCategoryId=40942&ref=25 A new class of nanoparticles hold promise for preventing premature drug release and offering greater accuracy and effectiveness in drug delivery. 2012-02-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/052012/757443null XML http://www.pharmtech.com/pharmtech/Ingredients+Insider/Expanding-Capabilities-in-the-Pharmaceutical-Cold-/ArticleStandard/Article/detail/757455?contextCategoryId=40942&ref=25 As biopharmaceutical development and commercialization increases, companies are expanding their cold-chain capabilities. 2012-02-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/052012/757455null XML http://www.pharmtech.com/pharmtech/Ingredients/Case-Studies-in-Pharmaceutical-Project-Management/ArticleStandard/Article/detail/757458?contextCategoryId=40942&ref=25 A technical forum featuring Catalent Pharma Solutions, SAFC, and Neuland Laboratories. 2012-02-01T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/052012/757458null XML http://www.pharmtech.com/pharmtech/Ingredients/Venture-Capital-Funding-Falls-but-Shows-Some-Momen/ArticleStandard/Article/detail/754378?contextCategoryId=40942&ref=25 Challenges remain, particularly for early-stage biopharmaceutical companies. 2012-01-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/532011/754378null XML http://www.pharmtech.com/pharmtech/Ingredients/Antibody-Drug-Conjugates-Looking-Ahead-to-an-Emerg/ArticleStandard/Article/detail/754373?contextCategoryId=40942&ref=25 Creating a successful antibody-drug conjugate requires careful selection of the drug, antibody, and linker. 2012-01-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/532011/754373/PT0112_Cover_120x90_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/532011/754373null XML http://www.pharmtech.com/pharmtech/Ingredients/FDA-Perspectives-Designation-of-Regulatory-Startin/ArticleStandard/Article/detail/754381?contextCategoryId=40942&ref=25 The author describes how providing appropriate information about the API in the Common Technical Document can aid FDA's review of an abbreviated new drug application. 2012-01-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/532011/754381/PT0112_64_FDA_fig4_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/532011/754381null XML http://www.pharmtech.com/pharmtech/Ingredients/Assessing-Tablet-Sticking-Propensity/ArticleStandard/Article/detail/754388?contextCategoryId=40942&ref=25 The authors designed an upper punch with a removable punch tip to determine a tablet formulation's propensity to stick by weighing the mass of powder adhered to the punch tip. 2012-01-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/532011/754388/PT0112_58_fig2_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/532011/754388null XML http://www.pharmtech.com/pharmtech/Ingredients+Insider/Broadening-the-Toolbox-in-Drug-Development-and-Ana/ArticleStandard/Article/detail/754374?contextCategoryId=40942&ref=25 Some recent advances involve strategies for accelerating reaction discovery, approaches for inducing chirality and stereochemical analysis, and applications in nanotechnology for protein elucidation. 2012-01-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/532011/754374null XML http://www.pharmtech.com/pharmtech/Ingredients/Views-from-Pharma-Leaders-A-Year-in-Review-and-a-L/ArticleStandard/Article/detail/751296?contextCategoryId=40942&ref=25 Drug shortages, supply-chain security, generic-drug incursion, and flexible manufacturing models are some of the issues shaping the bio/pharma industry. 2011-12-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492011/751296/PT1211_Cover_120-x-90_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492011/751296null XML http://www.pharmtech.com/pharmtech/Ingredients/PQRI-Case-Study-6-Packaging-Line-GMP-Optimization/ArticleStandard/Article/detail/751292?contextCategoryId=40942&ref=25 The sixth in a series of eight case studies from the Product Quality Research Institute focuses on packaging line GMP optimization. 2011-12-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492011/751292/PT1211_47_Case-Study-05-Table-2-Example-Frequency-Categories_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492011/751292null XML http://www.pharmtech.com/pharmtech/Ingredients/PQRI-Case-Study-8-Internal-GMP-Audit-Program/ArticleStandard/Article/detail/751282?contextCategoryId=40942&ref=25 The last in a series of eight case studies from the Product Quality Research Institute focuses on internal GMP audits. 2011-12-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492011/751282/PT1211_PQRICaseStudy8_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492011/751282/onlineEX_main.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492011/751282null XML http://www.pharmtech.com/pharmtech/Ingredients/The-Employment-Outlook-Brightens/ArticleStandard/Article/detail/751286?contextCategoryId=40942&ref=25 Readers react to the economic turmoil of the past year and look longingly forward to 2012. 2011-12-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492011/751286/PT1211_32_103772148_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492011/751286null XML http://www.pharmtech.com/pharmtech/Ingredients+Insider/Contract-API-Manufacturing-The-Year-in-Review/ArticleStandard/Article/detail/751298?contextCategoryId=40942&ref=25 Expansion activity was limited as fine-chemical producers and CMOs of API and intermediates grapple with changing industry fundamentals. 2011-12-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492011/751298null XML http://www.pharmtech.com/pharmtech/Ingredients/The-Development-of-a-Floating-Drug-Delivery-System/ArticleStandard/Article/detail/751293?contextCategoryId=40942&ref=25 The authors developed a metronidazole-based floating drug-delivery system to investigate the effect of rate-controlling polymers on release pattern and duration of buoyancy in matrix tablets. 2011-12-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492011/751293/PT1211_41_Colorcon_Opening_art_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492011/751293null XML http://www.pharmtech.com/pharmtech/Ingredients/PQRI-Case-Study-7-PackOut-Remedies-to-Minimize-Con/ArticleStandard/Article/detail/751283?contextCategoryId=40942&ref=25 The seventh in a series of eight case studies from the Product Quality Research Institute focuses on packout remedies. 2011-12-02T05:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492011/751283/PT1211_PQRICaseStudy7_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492011/751283/onlineEX_main.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/492011/751283null XML http://www.pharmtech.com/pharmtech/Ingredients+Insider/Catalyzing-the-Synthesis/ArticleStandard/Article/detail/747436?contextCategoryId=40942&ref=25 Researchers develop various catalytic approaches for improving yield, purity, stereoselectivity, and process conditions. 2011-11-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/452011/747436null XML http://www.pharmtech.com/pharmtech/Ingredients/Water-Intrusion-Test-Integration/ArticleStandard/Article/detail/747432?contextCategoryId=40942&ref=25 The authors describe the operational qualification of test accuracy with regard to temperature drift using a thermal-compensation algorithm on several freeze dryers. 2011-11-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/452011/747432null XML http://www.pharmtech.com/pharmtech/Ingredients/Near-Infrared-Analysis-of-Tablets-Containing-Two-A/ArticleStandard/Article/detail/747429?contextCategoryId=40942&ref=25 The study evaluates near-infrared analysis of tablets nominally containing 4 mg of chlorpheniramine maleate and 10 mg of phenylephrine hydrochloride per dose. 2011-11-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/452011/747429null XML http://www.pharmtech.com/pharmtech/Ingredients/PQRI-Case-Study-5-Nonsterile-Facility-Cleaning-Req/ArticleStandard/Article/detail/747435?contextCategoryId=40942&ref=25 The fifth in a series of eight case studies from the Product Quality Research Institute focuses on nonsterile facility cleaning requirements. 2011-11-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/452011/747435null XML http://www.pharmtech.com/pharmtech/Ingredients/PQRI-Case-Study-4-Process-Deviation-and-Empty-Prod/ArticleStandard/Article/detail/742120?contextCategoryId=40942&ref=25 This risk-management case study focuses on assessing empty capsules. 2011-10-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/402011/742120null XML http://www.pharmtech.com/pharmtech/Manufacturing/Pfizer-Outlines-Its-Supply-Strategy/ArticleStandard/Article/detail/746393?contextCategoryId=40942&ref=25 John Kelly, vice-president of strategy and transitioning sites for Pfizer Global Supply, discusses the company's manufacturing and supply strategy and network. 2011-10-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/442011/746393null HTML http://www.pharmtech.com/pharmtech/Ingredients/Quality-Issues-for-Multiregional-Clinical-Trial-Ma/ArticleStandard/Article/detail/742124?contextCategoryId=40942&ref=25 The authors examine risk management relating to the quality issues of clinical-trial materials and discuss areas that would benefit from additional consideration and harmonization. 2011-10-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/402011/742124/PT1011_78401002_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/402011/742124null XML http://www.pharmtech.com/pharmtech/Ingredients/Assessment-of-Large-Sample-Unit-Dose-Uniformity-Te/ArticleStandard/Article/detail/742135?contextCategoryId=40942&ref=25 The authors describe the concept of the limiting discriminatory the limiting discriminatory threshold (LDT) as an objective means of evaluating the inherent quality requirement of a large-sample content-uniformity test. 2011-10-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/402011/742135null XML http://www.pharmtech.com/pharmtech/Ingredients+Insider/Sizing-Up-the-Global-Market-for-Excipients/ArticleStandard/Article/detail/742121?contextCategoryId=40942&ref=25 The global excipients market shows moderate growth, increased consolidation, and expansion activity in emerging markets and select product areas. 2011-10-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/402011/742121null XML http://www.pharmtech.com/pharmtech/Ingredients/Novel-Excipients-A-Rare-Species/ArticleStandard/Article/detail/740932?contextCategoryId=40942&ref=25 Where are the new excipients, the new solubilisers and sustained release excipients? 2011-10-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/392011/740932null XML http://www.pharmtech.com/pharmtech/Ingredients/Regulators-Debate-Methods-for-Producing-Water-for-/ArticleStandard/Article/detail/738375?contextCategoryId=40942&ref=25 Might European officials reverse their position on acceptable production methods? 2011-09-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362011/738375/PT0911_RO_1_Page_25_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362011/738375null XML http://www.pharmtech.com/pharmtech/Ingredients/A-Design-of-Experiments-for-Tablet-Compression/ArticleStandard/Article/detail/738377?contextCategoryId=40942&ref=25 The author prepared and analyzed a detailed design of experiments for the manufacture of a simple tablet formulation. The aim was to test whether tablet hardness and weight could be controlled during the compression process by adjusting certain machine parameters. 2011-09-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362011/738377null XML http://www.pharmtech.com/pharmtech/Ingredients+Insider/Building-Toolboxes-in-Pursuit-of-Single-Enantiomer/ArticleStandard/Article/detail/738369?contextCategoryId=40942&ref=25 Biocatalysis, chemocatalysis, and other chiral technologies continue to attract the investment dollars of CMOs and fine-chemical companies. 2011-09-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362011/738369null XML http://www.pharmtech.com/pharmtech/Ingredients/A-Pharmaceutical-Companys-View-on-Supply-Chain-Sec/ArticleStandard/Article/detail/738754?contextCategoryId=40942&ref=25 The author offers perspectives on ways in which pharmaceutical companies and other stakeholders in the supply chain can confront the threat of counterfeit products, cargo theft, illegal diversion, and economically motivated adulteration. 2011-09-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/372011/738754null XML http://www.pharmtech.com/pharmtech/Ingredients/PQRI-Case-Study-3-Facility-Biocontainment-and-Inac/ArticleStandard/Article/detail/738383?contextCategoryId=40942&ref=25 The third in a series of eight case studies from the Product Quality Research Institute focuses on facility biocontainment and inactivation. 2011-09-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362011/738383null XML http://www.pharmtech.com/pharmtech/Ingredients/Web-20-for-Pharma-Innovation/ArticleStandard/Article/detail/738382?contextCategoryId=40942&ref=25 Internal and external Web-based communities are changing how pharma companies can innovate. 2011-09-02T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362011/738382null XML http://www.pharmtech.com/pharmtech/Ingredients/Atypical-Actives-Gain-Attention/ArticleStandard/Article/detail/738393?contextCategoryId=40942&ref=25 Clarifying GMPs for excipients used as actives. 2011-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362011/738393null XML http://www.pharmtech.com/pharmtech/Ingredients/Improving-RampD-with-API-microdosing/ArticleStandard/Article/detail/740545?contextCategoryId=40942&ref=25 Direct dosing APIs during R&D studies can reduce the overall testing time of a drug candidate by allowing for a greater throughput of compounds through the R&D department. 2011-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/392011/740545/crossword_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/392011/740545null XML http://www.pharmtech.com/pharmtech/Manufacturing/Carbohydrates-For-Injection/ArticleStandard/Article/detail/737356?contextCategoryId=40942&ref=25 Elham Blouet from Roquette explains the importance of carbohydrates for injection and the challenges in this niche market. 2011-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/352011/737356null XML http://www.pharmtech.com/pharmtech/Ingredients/Achieving-Containment-in-High-Potency-Manufacturin/ArticleStandard/Article/detail/738392?contextCategoryId=40942&ref=25 A Q&A with Joe Cascone, director of potent pharmaceutical development at Metrics, moderated by Patricia Van Arnum. Discussion of the key considerations made in facility design, equipment selection, and operations to achieve desired levels of containment. 2011-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362011/738392null XML http://www.pharmtech.com/pharmtech/Ingredients/HPAPIs-And-Bioconjugates/ArticleStandard/Article/detail/737357?contextCategoryId=40942&ref=25 The market for HPAPIs is growing rapidly with the research industry's emphasis on oncology. 2011-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/352011/737357null XML http://www.pharmtech.com/pharmtech/Ingredients/Manufacturing-Perspectives-Lessons-for-Biomanufact/ArticleStandard/Article/detail/738389?contextCategoryId=40942&ref=25 A perspective from Pfizer on the lessons from small-molecule manufacturing that can be applied to biomanufacturing. 2011-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362011/738389null XML http://www.pharmtech.com/pharmtech/Ingredients/API-Market-Challenges/ArticleStandard/Article/detail/738454?contextCategoryId=40942&ref=25 The increasing cost of crucial manufacturing input factors, such as energy and raw materials, has been a severe threat to several companies. 2011-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/372011/738454/crossword_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/372011/738454null XML http://www.pharmtech.com/pharmtech/Ingredients/A-Suppliers-Role-in-Ensuring-and-Improving-Excipie/ArticleStandard/Article/detail/738388?contextCategoryId=40942&ref=25 Excipients are the hidden champions of drug development—no API works consistently without the right excipient. Pharmaceutical excipients, however, require stringent quality management. This article discusses how the supplier of pharmaceutical raw materials should take a central role in ensuring excipient quality. 2011-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362011/738388null XML http://www.pharmtech.com/pharmtech/Ingredients/Addressing-Ways-to-Improve-Supply-Chain-Security-A/ArticleStandard/Article/detail/738386?contextCategoryId=40942&ref=25 A Q&A with Brian Johnson, senior director of supply chain security at Pfizer, moderated by Patricia Van Arnum. Part of a special Ingredients issue. 2011-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362011/738386/PT0911_96251967_web_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/362011/738386null XML http://www.pharmtech.com/pharmtech/Ingredients/Highly-Potent-Highly-Challenging/ArticleStandard/Article/detail/737348?contextCategoryId=40942&ref=25 Highly potent APIs (HPAPIs) represent a growing area of interest for the pharma industry. Mark Griffiths, CEO of Carbogen Amcis AG, explains why. 2011-09-01T04:00:00Z http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/352011/737348/crossword_thumbnail.jpg http://www.pharmtech.com/pharmtech/data/articlestandard/pharmtech/352011/737348null XML